Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xing Wu

Showing results (61-70 of 1,271) with videos related to

Pageof 128
Sort By:
Skin Pharmacology and Physiology|August 12, 2022
Sinomenine Suppressed Keratinocyte Proliferation and Imiquimod-Induced Psoriasis-Like Dermatitis by Regulating lncRNA XISTShoubao Xiang, Xing Wu, Yu Xiang
Free Radical Biology & Medicine|December 4, 2003
The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicinBrian B Hasinoff, Daywin Patel, Xing Wu
Journal of Inorganic Biochemistry|November 4, 2004
The iron chelating cardioprotective prodrug dexrazoxane does not affect the cell growth inhibitory effects of bleomycinXing Wu, Daywin Patel, Brian B Hasinoff
Organic & Biomolecular Chemistry|January 11, 2019
Base-promoted direct synthesis of functionalized N-arylindoles via the cascade reactions of allenic ketones with indolesShengxiao Li, Xin-Xing Wu, Shufeng Chen
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|October 1, 2008
[Clinical effect of ligustrazine combined with citicoline for treatment of diabetic peripheral neuropathy]Ya Liu, Ning Li, Xing-Wu Ran
Journal of Inorganic Biochemistry|March 26, 2004
Synthesis and characterization of the biological activity of the cisplatin analogs, cis-PtCl(2)(dexrazoxane) and cis-PtCl(2)(levrazoxane), of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186)Brian B Hasinoff, Xing Wu, Yuwei Yang
Scientific Reports|January 9, 2015
Enhanced multiple vibrational resonances by Na+ and K+ dynamics in a neuron modelXing-Xing Wu, Chenggui Yao, Jianwei Shuai
Journal of Cheminformatics|December 30, 2025
Capsule graph networks for accurate and interpretable crystalline materials property predictionXing Wu, Eddah K Sure, Quan Qian
Cardiovascular Toxicology|November 28, 2019
The Role of Topoisomerase IIβ in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent DexrazoxaneBrian B Hasinoff, Daywin Patel, Xing Wu
Antiviral Research|April 22, 2017
Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factorKan Xing Wu, Justin Jang-Hann Chu
Pageof 128

Showing results (61-70 of 1,271) with videos related to

Sort By:
Pageof 128
Skin Pharmacology and Physiology|August 12, 2022
Sinomenine Suppressed Keratinocyte Proliferation and Imiquimod-Induced Psoriasis-Like Dermatitis by Regulating lncRNA XISTShoubao Xiang, Xing Wu, Yu Xiang
Free Radical Biology & Medicine|December 4, 2003
The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicinBrian B Hasinoff, Daywin Patel, Xing Wu
Journal of Inorganic Biochemistry|November 4, 2004
The iron chelating cardioprotective prodrug dexrazoxane does not affect the cell growth inhibitory effects of bleomycinXing Wu, Daywin Patel, Brian B Hasinoff
Organic & Biomolecular Chemistry|January 11, 2019
Base-promoted direct synthesis of functionalized N-arylindoles via the cascade reactions of allenic ketones with indolesShengxiao Li, Xin-Xing Wu, Shufeng Chen
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|October 1, 2008
[Clinical effect of ligustrazine combined with citicoline for treatment of diabetic peripheral neuropathy]Ya Liu, Ning Li, Xing-Wu Ran
Journal of Inorganic Biochemistry|March 26, 2004
Synthesis and characterization of the biological activity of the cisplatin analogs, cis-PtCl(2)(dexrazoxane) and cis-PtCl(2)(levrazoxane), of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186)Brian B Hasinoff, Xing Wu, Yuwei Yang
Scientific Reports|January 9, 2015
Enhanced multiple vibrational resonances by Na+ and K+ dynamics in a neuron modelXing-Xing Wu, Chenggui Yao, Jianwei Shuai
Journal of Cheminformatics|December 30, 2025
Capsule graph networks for accurate and interpretable crystalline materials property predictionXing Wu, Eddah K Sure, Quan Qian
Cardiovascular Toxicology|November 28, 2019
The Role of Topoisomerase IIβ in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent DexrazoxaneBrian B Hasinoff, Daywin Patel, Xing Wu
Antiviral Research|April 22, 2017
Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factorKan Xing Wu, Justin Jang-Hann Chu
Pageof 128